After the FDA’s approval, suzetrigine became the first new painkiller approved in the US in 27 years. Journavx was evaluated in two randomized controlled trials of acute surgical pain.

DAVENPORT, Iowa (KWQC) - The Food and Drug Administration recently approved Journavx to treat short-term pain. It’s a new class of non-opioid pain medication for treating adults and the first ...

Call your doctor right away if you think you’ve taken too much Journavx. You can also call 800-222-1222 to reach America’s Poison Centers or use its online resource. But if you have severe ...

Vertex's Journavx, targeting NaV1.8, is FDA-approved and shows opioid-level pain relief with fewer side effects, positioning it as a potential new standard of care.